Related Experiment Video
Updated: Aug 5, 2026
06:38
An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
Radiotherapy and Immunotherapy In Hepatocellular Carcinoma: Priming the Tumor Immune Microenvironment From Bench To
Zhigang Fu1, Yang Zhang1, Zuomin Wang2
1Department of Radiation Oncology Cancer Center Zhongshan Hospital Fudan University Shanghai China.
Precision Radiation Oncology
|July 25, 2026
Summary
Radiotherapy can enhance immunotherapy for hepatocellular carcinoma (HCC) by modulating the tumor microenvironment (TME). Combining these treatments shows promise for managing advanced liver cancer.
Area of Science:
- Oncology
- Immunology
- Radiotherapy
Background:
- Hepatocellular carcinoma (HCC) is a major global cancer mortality cause.
- While surgery is curative for early HCC, advanced stages need multidisciplinary approaches like radiotherapy and immunotherapy.
- Advances in radiation delivery allow precise tumor targeting, increasing radiotherapy's role beyond palliation.
Purpose of the Study:
- To review the immunomodulatory effects of radiotherapy on the tumor microenvironment (TME) in HCC.
- To explore the rationale for combining radiotherapy with immunotherapy for HCC.
- To summarize preclinical and clinical evidence for HCC radiotherapy-immunotherapy combinations.
Main Methods:
- Systematic review of literature on radiotherapy's effects on the HCC TME.
- Examination of biological mechanisms underlying radiotherapy-immunotherapy synergy.
- Summary of preclinical and clinical data supporting combined treatment strategies.
Main Results:
- Radiotherapy significantly impacts the TME, influencing immune cell infiltration and function.
- Combining radiotherapy with immunotherapy demonstrates synergistic effects in preclinical models.
- Early clinical data suggest potential benefits of combined approaches in HCC patients.
Conclusions:
- Radiotherapy can be strategically combined with immunotherapy to enhance HCC treatment outcomes.
- Understanding the TME modulation by radiotherapy is crucial for optimizing combination therapies.
- Further translational and clinical research is essential to fully leverage this therapeutic strategy for HCC.
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...